These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20472375)

  • 1. Effect of ibuprofen on bilirubin-albumin binding in vitro at concentrations observed during treatment of patent ductus arteriosus.
    Diot C; Kibleur Y; Desfrere L
    Early Hum Dev; 2010 May; 86(5):315-7. PubMed ID: 20472375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ibuprofen on bilirubin-albumin binding during the treatment of patent ductus arteriosus in preterm infant.
    Thibaut C; Hazard A; Huon C; Desfrere L
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():7-9. PubMed ID: 21815876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbound bilirubin does not increase during ibuprofen treatment of patent ductus arteriosus in preterm infants.
    Desfrere L; Thibaut C; Kibleur Y; Barbier A; Bordarier C; Moriette G
    J Pediatr; 2012 Feb; 160(2):258-264.e1. PubMed ID: 21875717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ibuprofen L-lysinate on bilirubin binding to albumin as measured by saturation index and horseradish peroxidase assays.
    Ambat MT; Ostrea EM; Aranda JV
    J Perinatol; 2008 Apr; 28(4):287-90. PubMed ID: 18200021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
    Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
    J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Displacement of bilirubin from albumin by ibuprofen in vitro.
    Soligard HT; Nilsen OG; Bratlid D
    Pediatr Res; 2010 Jun; 67(6):614-8. PubMed ID: 20216106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants.
    Rheinlaender C; Helfenstein D; Walch E; Berns M; Obladen M; Koehne P
    Acta Paediatr; 2009 Jan; 98(1):36-42. PubMed ID: 18764861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ibuprofen on bilirubin-albumin binding.
    Ahlfors CE
    J Pediatr; 2004 Mar; 144(3):386-8. PubMed ID: 15001951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ibuprofen on bilirubin-albumin binding affinity in premature infants.
    Amin SB; Miravalle N
    J Perinat Med; 2011 Jan; 39(1):55-8. PubMed ID: 20954849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Ibuprofen increase neonatal hyperbilirubinemia?
    Zecca E; Romagnoli C; De Carolis MP; Costa S; Marra R; De Luca D
    Pediatrics; 2009 Aug; 124(2):480-4. PubMed ID: 19620202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants.
    Richards J; Johnson A; Fox G; Campbell M
    Pediatrics; 2009 Aug; 124(2):e287-93. PubMed ID: 19651568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus.
    Van Overmeire B; Touw D; Schepens PJ; Kearns GL; van den Anker JN
    Clin Pharmacol Ther; 2001 Oct; 70(4):336-43. PubMed ID: 11673749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus.
    Van Overmeire B
    Int J Clin Pract Suppl; 2003 Apr; (135):23-7. PubMed ID: 12723743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unbound bilirubin concentration is associated with abnormal automated auditory brainstem response for jaundiced newborns.
    Ahlfors CE; Parker AE
    Pediatrics; 2008 May; 121(5):976-8. PubMed ID: 18450902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants.
    Oncel MY; Yurttutan S; Uras N; Altug N; Ozdemir R; Ekmen S; Erdeve O; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2013 Jan; 98(1):F94. PubMed ID: 22611117
    [No Abstract]   [Full Text] [Related]  

  • 20. Does ibuprofen affect bilirubin-albumin binding in newborn infant serum?
    Cooper-Peel C; Brodersen R; Robertson A
    Pharmacol Toxicol; 1996 Dec; 79(6):297-9. PubMed ID: 9000255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.